抗干扰素-α自身抗体胸腺瘤患者发生危及生命的COVID-19

IF 4.5 2区医学 Q2 IMMUNOLOGY

Journal of Microbiology Immunology and Infection Pub Date : 2025-02-05 DOI:10.1016/j.jmii.2025.02.002

Yu-Shan Shih , Wan-Ting Tsai , Bei-Chia Guo , Aristine Cheng , Jann-Tay Wang

引用次数: 0

摘要

中和抗干扰素(IFN)-α自身抗体可导致免疫失调，可能导致2019冠状病毒病（COVID-19）。我们报告了一例严重的COVID-19患者，随后被诊断为胸腺瘤和中和抗ifn -α自身抗体。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Life-threatening COVID-19 in a thymoma patient with anti-interferon-α autoantibodies

Neutralizing anti-interferon (IFN)-α autoantibodies can lead to immune dysregulation, potentially resulting in critical coronavirus disease 2019 (COVID-19). We report a case presenting with severe COVID-19 who was subsequently diagnosed to have thymoma and neutralizing anti-IFN-α autoantibodies.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Microbiology Immunology and Infection IMMUNOLOGY-INFECTIOUS DISEASES

CiteScore

15.90

自引率

5.40%

发文量

159

审稿时长

67 days

期刊介绍： Journal of Microbiology Immunology and Infection is an open access journal, committed to disseminating information on the latest trends and advances in microbiology, immunology, infectious diseases and parasitology. Article types considered include perspectives, review articles, original articles, brief reports and correspondence. With the aim of promoting effective and accurate scientific information, an expert panel of referees constitutes the backbone of the peer-review process in evaluating the quality and content of manuscripts submitted for publication.